Kate Newbold

Kate Newbold is a leading thyroid cancer clinician at the Royal Marsden Hospital in London with expertise in radioiodine-refractory differentiated thyroid cancer. She has contributed to international clinical trials evaluating novel kinase inhibitors and combination regimens for advanced thyroid disease. Her work includes studies on optimizing radioiodine dosing and patient selection for systemic therapy. She is an active contributor to European thyroid oncology guidelines.